METABOLIC SYNDROME AND ITS ENDOCRINOLOGICAL ASPECTS IN CLINICAL PRACTICE
Article Sidebar
Main Article Content
Abstract
Metabolic syndrome is a cluster of interconnected metabolic and endocrine disorders, including abdominal obesity, insulin resistance, dyslipidemia, and hypertension. It significantly increases the risk of developing type 2 diabetes mellitus and cardiovascular diseases, which are leading causes of morbidity and mortality worldwide. This article provides a comprehensive review of the pathophysiology, clinical features, diagnostic approaches, and management strategies of metabolic syndrome from an endocrinological perspective. The findings emphasize the importance of early identification, lifestyle modification, and targeted hormonal therapy in improving patient outcomes.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Alberti KG, Zimmet P, Shaw J. (2006). Metabolic syndrome—a new world-wide definition. Lancet, 366(9491), 1059–1062.
2.International Diabetes Federation. (2023). IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF.
3.Grundy SM. (2016). Metabolic syndrome update. Trends Cardiovasc Med, 26(4), 364–373.
4.Eckel RH, Kahn R, Robertson RM, Rizza RA. (2018). Preventing cardiovascular disease and diabetes: A call to action from the American Diabetes Association and American Heart Association. Circulation, 117(23), 3244–3252.
5.Bray GA, Kim KK, Wilding JPH. (2017). Obesity: A chronic relapsing progressive disease process. Obes Rev, 18(7), 715–723.